Solutions from Process Development to Commercial Manufacturing for mAbs
Scalable and Cost-Efficient Single-Use Toolbox for Your mAb Process Platform
By combining our expertise in cell line development and cultivation, media optimization, virus clearance, filtration and polishing of mAbs we provide a complete Toolbox of Solutions which can be adapted in-house or at contract manufacturing organizations.
Speed your Upstream Development and Simplify Manufacturing - From 15 mL to 2000 L
Tackle your Downstream Bottlenecks - From mg to kg of mAbs
Technologies that enable intensified production throughout the process
Sample media for recombinant proteins and monoclonal antibodies (mAbs).Request Your Sample
Albumedix´ solutions enable the development and commercialization of advanced therapies and next-generation biopharmaceuticals.
In an exclusive interview with Miriam Monge, Head of Segment Marketing mAb at Sartorius, Nienke Vriezen, Synthon’s Director of USP Development and Manufacturing talks about how Sartorius helped Synthon to rapidly implement a flexible single-use facility for the manufacture of monoclonal antibodies.Founded in 1991, Synthon now employs 1,700 people at nine sites worldwide. The company develops biopharmaceuticals with a focus is on next-generation cancer drugs.
Contact our Experts
See first-hand how Sartobind® Rapid A delivers a tenfold increase in productivity with Sartorius’ new chromatography membrane. Learn more about the product’s scalability, from PD to commercial, and how to remove the mAb capture bottleneck in this webinar.
Watch Now
Learn how Sartorius’ new single-use technologies meet the growing demands of clinical commercial biopharmaceutical environments.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.